VisionPoint Advisory Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
414
-37
-8% -$17.1K 0.04% 446
2026
Q1
$217K Buy
451
+26
+6% +$13.3K 0.04% 414
2025
Q4
$239K Sell
425
-25
-6% -$14.2K 0.05% 348
2025
Q3
$231K Buy
+450
New +$196K 0.05% 356
2024
Q3
Sell
-69
Closed -$28.4K 560
2024
Q2
$28.4K Buy
69
+29
+73% +$11.5K 0.01% 348
2024
Q1
$16.2K Sell
40
-2
-5% -$703 0.01% 406
2023
Q4
$12.9K Sell
42
-19
-31% -$5.13K ﹤0.01% 395
2023
Q3
$14.8K Buy
+61
New +$15.6K 0.01% 412

Other funds holding MEDP

VisionPoint Advisory Group's MEDP Position: Q2 2026 in Review

VisionPoint Advisory Group reduced its Medpace (MEDP) stake by 8.2% in Q2 2026, selling an estimated $17.1K and leaving 414 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #446.

VisionPoint Advisory Group first reported a position in MEDP in Q3 2023 and has held it in 8 quarters since. The position peaked at $239K in Q4 2025. 75 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • VisionPoint Advisory Group held 414 shares of Medpace worth $219K as of Q2 2026.
  • VisionPoint Advisory Group sold 37 Medpace shares in Q2 2026, an estimated $17.1K.
  • Medpace made up 0.04% of VisionPoint Advisory Group's portfolio in Q2 2026, its #446 holding.
  • VisionPoint Advisory Group first reported a position in Medpace in Q3 2023 and has held it in 8 quarters since.
  • VisionPoint Advisory Group's Medpace position peaked at $239K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.